Extension Study of Long-term Safety and Efficacy of Myozyme for a Single Patient With Pompe Disease Who Were Previously Enrolled in Genzyme Sponsored ERT Studies.

NCT00765414 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

1

Enrollment

INDUSTRY

Sponsor class

Conditions

Pompe Disease Late-Onset
Glycogen Storage Disease Type II GSD II

Interventions

BIOLOGICAL: Myozyme

Sponsor

Genzyme, a Sanofi Company